Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Jódar Gimeno, José Esteban; Polonsky, William; Réa, Rosangela; Warren, Mark; Vilsbøll, Tina; Hakan Bloch, J.; Vrazic, H.; Lindeberg, Staffan; Bain, Stephen

Español
English |

Home

Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Jódar Gimeno, José Esteban; Polonsky, William; Réa, Rosangela; Warren, Mark; Vilsbøll, Tina; Hakan Bloch, J.; Vrazic, H.; Lindeberg, Staffan; Bain, Stephen

Use this identifier to cite or link to this item: http://hdl.handle.net/11268/10013

Date: 2018

UNESCO Subject: Medicina preventiva
UNESCO Subject: Enfermedad cardiovascular

Type: conferenceObject

Exportar a:

Show full item record

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Otras Áreas de Investigación de Salud y Ciencias Biomédicas [2718]

Search ABACUS

Browse

All of ABACUS
This Collection

Statistics

View usage statistics

Topics of interest

Dissertations
Journals
Last submissions

Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

ABACUS/Manakin Repository

Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Files in this item

This item appears in the following Collection(s)

Search ABACUS

Browse

All of ABACUS

This Collection

Statistics

Topics of interest

Other links

Follow us:

Social networks